Gsk (GSK) Other Non-Current Assets (2009 - 2026)

Gsk (GSK) has 10 years of Other Non-Current Assets data on file, last reported at $2.9 billion in Q4 2025.

• In Q4 2025, Other Non-Current Assets rose 14.63% year-over-year to $2.9 billion; the TTM figure through Dec 2025 stood at $2.9 billion (up 14.63% YoY), while the FY2025 annual figure was $2.9 billion, up 14.63% from the prior year.
• Other Non-Current Assets improved to $2.9 billion in Q4 2025, from $2.5 billion in the prior quarter.
• Across five years, Other Non-Current Assets topped out at $2.9 billion in Q4 2025 and bottomed at $1.4 billion in Q4 2022.
• A 5-year average of $2.2 billion and a median of $2.3 billion in 2021 frame the typical range for Other Non-Current Assets.
• Annual changes were most pronounced in 2021 — Other Non-Current Assets soared 64.36% — and 2022, when it slumped 38.01%.
• Year by year, Other Non-Current Assets stood at $2.3 billion in 2021, then slumped by 38.01% to $1.4 billion in 2022, then jumped by 40.38% to $2.0 billion in 2023, then grew by 26.78% to $2.5 billion in 2024, then advanced by 14.63% to $2.9 billion in 2025.
• The last three Other Non-Current Assets figures came in at $2.9 billion (Q4 2025), $2.5 billion (Q4 2024), and $2.0 billion (Q4 2023), per Business Quant data.

Peer Comparison